SMAS Stock Overview
Somatic Systems, Inc. provides drug-free and non-surgical approach to movement disorders, musculoskeletal problems, and pain relief.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Somatic Systems, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.000001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -99.50% |
| 5 Year Change | 0% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| SMAS | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -1.3% | -3.5% |
| 1Y | n/a | -2.9% | 20.2% |
Return vs Industry: Insufficient data to determine how SMAS performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how SMAS performed against the US Market.
Price Volatility
| SMAS volatility | |
|---|---|
| SMAS Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: SMAS has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SMAS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | n/a | Steven Aronstein | www.somatics.org |
Somatic Systems, Inc. provides drug-free and non-surgical approach to movement disorders, musculoskeletal problems, and pain relief. The company offers a system that uses natural non-invasive movement techniques conducted through one-hour hands-on sessions, therapeutic exercises classes, and home exercises to relieve pain and limitation resulting from accident, trauma, and repetitive stress, including back pain, knee pain, joint problems, carpal tunnel syndrome, TMJ, scoliosis, bursitis, sciatica, headaches, tendonitis, and more. It also provides performance gains and injury prevention for casual and professional athletes.
Somatic Systems, Inc. Fundamentals Summary
| SMAS fundamental statistics | |
|---|---|
| Market cap | US$14.60k |
| Earnings (TTM) | -US$239.08k |
| Revenue (TTM) | US$107.42k |
0.0x
P/S Ratio0.0x
P/E RatioIs SMAS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SMAS income statement (TTM) | |
|---|---|
| Revenue | US$107.42k |
| Cost of Revenue | US$9.76k |
| Gross Profit | US$97.66k |
| Other Expenses | US$336.74k |
| Earnings | -US$239.08k |
Last Reported Earnings
Dec 31, 2008
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did SMAS perform over the long term?
See historical performance and comparison